TOMM20 and renal carcinoma: As shown in Fig 3E, we identified that TOM20, TOM40, and TOM70 proteins were decreased following TEMS treatment in the malignant renal cancer cell lines (most notably in 786-O cells) in addition to HK-2 cells.